The specific implication of the PSMC3 subunit is supported by genetic fine mapping that identified PSMC3 among others at the CELF1/SPI1 locus [43] and methylation QTL studies that implicate differential methylation at the locus in AD risk [44]. This evidence concerns the gene CELF1 and Alzheimer disease.